These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24390241)

  • 1. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.
    Ye Z; Wang S; Yang Z; He M; Zhang S; Zhang W; Wen J; Li Q; Huang Y; Wang X; Lu B; Zhang Z; Su Q; Hu R
    Mol Biol Rep; 2014 Mar; 41(3):1317-23. PubMed ID: 24390241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
    Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
    Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum chemerin and vaspin in non-alcoholic fatty liver disease.
    Kukla M; Zwirska-Korczala K; Hartleb M; Waluga M; Chwist A; Kajor M; Ciupinska-Kajor M; Berdowska A; Wozniak-Grygiel E; Buldak R
    Scand J Gastroenterol; 2010; 45(2):235-42. PubMed ID: 20095887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
    Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
    Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Eren F; Ozdogan O; Celikel CA; Imeryuz N; Kalayci C; Avsar E
    Scand J Gastroenterol; 2011 Jan; 46(1):91-7. PubMed ID: 20809771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
    Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
    Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
    Hatziagelaki E; Herder C; Tsiavou A; Teichert T; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M
    PLoS One; 2015; 10(5):e0124935. PubMed ID: 25933030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.
    Döcke S; Lock JF; Birkenfeld AL; Hoppe S; Lieske S; Rieger A; Raschzok N; Sauer IM; Florian S; Osterhoff MA; Heller R; Herrmann K; Lindenmüller S; Horn P; Bauer M; Weickert MO; Neuhaus P; Stockmann M; Möhlig M; Pfeiffer AF; von Loeffelholz C
    Eur J Endocrinol; 2013 Nov; 169(5):547-57. PubMed ID: 23935128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
    Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis.
    Meier EM; Pohl R; Rein-Fischboeck L; Schacherer D; Eisinger K; Wiest R; Krautbauer S; Buechler C
    Cytokine; 2016 Sep; 85():45-50. PubMed ID: 27288631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.
    Huang Y; Yang Z; Ye Z; Li Q; Wen J; Tao X; Chen L; He M; Wang X; Lu B; Zhang Z; Zhang W; Qu S; Hu R
    Cardiovasc Diabetol; 2012 Jan; 11():11. PubMed ID: 22292925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.
    Bekaert M; Ouwens DM; Hörbelt T; Van de Velde F; Fahlbusch P; Herzfeld de Wiza D; Van Nieuwenhove Y; Calders P; Praet M; Hoorens A; Geerts A; Verhelst X; Kaufman JM; Lapauw B
    Obesity (Silver Spring); 2016 Dec; 24(12):2544-2552. PubMed ID: 27768254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
    Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
    Park CG; Choi KM
    Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
    Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO
    Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".
    Kanaka-Gantenbein C; Margeli A; Pervanidou P; Sakka S; Mastorakos G; Chrousos GP; Papassotiriou I
    Clin Chem; 2008 Jul; 54(7):1176-82. PubMed ID: 18487287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.